Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72632 record(s)

Req # A-2020-000175

Adverse Reaction Report (AER) for botulinum toxin A. Report number: E2B_02985683.

Organization: Health Canada

15 page(s)
August 2020

Req # A-2020-000204

Adverse Reaction Report (AER) for PMS-AZITHROMYCIN. Report number: E2B_02972093.

Organization: Health Canada

23 page(s)
August 2020

Req # A-2020-000210

Adverse Reaction Report (AER). Report numbers: 000504926, E2B_02938670, E2B_02403401, 000725458.

Organization: Health Canada

45 page(s)
August 2020

Req # A-2020-000225

Adverse Reaction Report (AER) for M-M-R II. Report number: 000676417.

Organization: Health Canada

6 page(s)
August 2020

Req # A-2020-000231

Adverse Reaction Report (AER) for PROMETRIUM. Report numbers: 000664347, E2B_00451784.

Organization: Health Canada

150 page(s)
August 2020

Req # A-2020-000248

Adverse Reaction Report (AER) for CLOPIDOGREL BISULFATE. Report number: 729743.

Organization: Health Canada

42 page(s)
August 2020

Req # A-2020-000288

Adverse Reaction Report (AER) for botulinum toxin type A. Report number: E2B_02466259.

Organization: Health Canada

8 page(s)
August 2020

Req # A-2020-000336

Adverse Reaction Report (AER) for SARILUMAB. Report number: E2B_02917832.

Organization: Health Canada

14 page(s)
August 2020

Req # A-2020-000338

Adverse Reaction Report (AER) for ANTI-THYMOCYTE GLOBULIN (RABBIT). Report numbers: E2B_02764378, E2B_02233985, E2B_02799565.

Organization: Health Canada

29 page(s)
August 2020

Req # A-2020-000512

Adverse Reaction Report (AER). Report number: 000911695.

Organization: Health Canada

10 page(s)
August 2020
Date modified: